Randomized Controlled Trial and Correlation Analysis of Gandouling Tablet in Treatment of Abnormal Lipid Metabolism of Wilson's Disease with Turbid Phlegm and Blood Stasis
10.13422/j.cnki.syfjx.20241592
- VernacularTitle:肝豆灵片治疗痰瘀互结型肝豆状核变性脂代谢异常的随机对照试验及相关性分析
- Author:
Feng LIANG
1
;
Ting DONG
1
;
Liwei TIAN
1
;
Chenling ZHAO
1
;
Ruixue GUO
1
;
Qiong WANG
1
;
Yuqi ZHANG
1
Author Information
1. The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China
- Publication Type:Journal Article
- Keywords:
Wilson's disease;
abnormal lipid metabolism;
Gandouling tablet;
prediction model;
ultrasound attenuation coefficient imaging
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(12):121-128
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the clinical efficacy of Gandouling tablet (GDL) on abnormal lipid metabolism in Wilson's disease (WD) and the correlation between the prediction model of hepatic steatosis and the related indexes of lipid metabolism in WD. MethodA total of 86 patients with abnormal lipid metabolism in WD were selected. The 24-hour urine copper, alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum triglyceride (TG), total cholesterol (TC), apolipoprotein B (ApoB), low density lipoprotein cholesterol (LDL-C), bile acid (BA), γ-glutamyl transferase (GGT), prediction model of hepatic steatosis [hepatic steatosis index (HSI) and Zhejiang University index (ZJU index)], ultrasonic attenuation coefficient imaging (ATT), and traditional Chinese medicine (TCM) syndrome score were statistically analyzed before treatment. Pearson correlation test was used to analyze the correlation between TG, TC, LDL-C, ApoB, ALT, AST, ALT/AST, BA, GGT, TCM syndrome score, ATT, and HIS and ZJU. The patients were divided into an observation group and a control group by random number table method, with 43 cases in each group. The observation group was treated with GDL combined with sodium dimercaptopropane sulfonate (DMPS), while the control group was only treated with DMPS as a control. After six courses of treatment, 24-hour urine copper, TC, TG, LDL-C, ApoB, HSI, ZJU, ATT, TCM syndrome score, and clinical efficiency before and after treatment were observed and compared between the two groups. The correlation between HSI and ZJU and serum TC, TG, LDL-C, ApoB, ALT, AST, ALT/AST, BA, GGT, TCM syndrome scores, and ATT was analyzed. ResultPearson correlation analysis showed that serum TC (r = 0.811), TG (r = 0.826), LDL-C (r = 0.802), ApoB (r = 0.820), ALT (r = 0.497), ALT/AST (r = 0.826), TCM syndrome score (r = 0.716), and ATT (r = 0.736) were positively correlated with HSI (P<0.01), while AST, BA, and GGT had no significant correlation with HSI. TC (r = 0.718), TG (r = 0.765), LDL-C (r = 0.667), ApoB (r = 0.699), ALT/AST (r = 0.403), TCM syndrome score (r = 0.666), and ATT (r = 0.684) were positively correlated with ZJU (P<0.01). ALT, AST, BA, and GGT had no significant correlation with ZJU. The total effective rate of the observation group was 86.05 (37/43), and that of the control group was 72.09% (31/43). The total effective rate of the observation group was higher than that of the control group (Z = -2.301, P<0.05). After treatment, the 24-hour urine copper of the two groups increased significantly. The levels of TC, TG, LDL-C, and ApoB were significantly decreased, and the HSI, ZJU, and ATT were significantly decreased (P<0.01). Compared with those in the control group after treatment, the above indexes improved better in the observation group (P<0.05, P<0.01). ConclusionGDL can effectively improve the level of copper and lipid metabolism in patients with WD, with high clinical safety and good clinical application value. The prediction model of hepatic steatosis can effectively reflect the degree of abnormal lipid metabolism in WD.